Study of platelet adhesion in patients with uncomplicated hypertension

Journal of Hypertension

Volumn 14, Issue 10, 1996, Pages 1215-1221

  Andrioli, Giuseppe ^a   Ortolani, Riccardo ^a   Fontana, Luigi ^a   Gaino, Stefania ^a   Bellavite, Paolo ^a   Lechi, Clara ^a   Minuz, Pietro ^a   Manzato, Franco ^a   Tridente, Giuseppe ^a   Lechi, Alessandro ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Adhesion; Essential hypertension; Flow cytometry; Platelets; Von Willebrand factor; thromboglobulin

Indexed keywords

ACID PHOSPHATASE; BETA THROMBOGLOBULIN; FIBRINOGEN RECEPTOR; GLYCOPROTEIN; MONOCLONAL ANTIBODY; PADGEM PROTEIN; THROMBIN; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; CELL SIZE; COLORIMETRY; CONTROLLED STUDY; ENZYME ACTIVITY; ESSENTIAL HYPERTENSION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE ADHESION; THROMBOCYTE FUNCTION;

EID: 10244236589     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199610000-00010     Document Type: Article

References (30)

1. Lechi A, Lechi C, Lauciello C, Guzzo P, Arosio E, Minuz P, et al.: Platelet abnormalities in human hypertension. In Cellular Aspects of Hypertension. Edited by Bruschi G, Borghetli A. Berlin: Springer-Verlag; 1991:227-236.
2. Vlachakis ND, Aledort L: Hypertension and propranolol therapy: effect on blood pressure, plasma catecholamines and platelet aggregation. Am J Cardiol 1980, 45:321-325.
3. Nyrop M, Zweifler AJ: Platelet aggregation in hypertension and the effects of antihypertensive treatment [editorial review]. J Hypertens 1988, 6:263-269.
4. Bruschi G, Minari M, Bruschi ME, Tacinelli L, Milani B, Cavatorta A, et al.: Similarities of essential and experimental hypertension: volume and number of blood cells. Hypertension 1986, 8:983-989.
5. Lande K, Os I, Kjeldsen SE, Westheim A, Hjermann I, Eide I, et al.: Increased platelet size and release reaction in essential hypertension. J Hypertens 1987, 5:401-406.
6. Gomi T, Ikeda T, Yuhara M, Sakurai J, Nakayama D, Ikegami F: Plasma β-thromboglobulin to platelet factor 4 ratios as indices of vascular complications in essential hypertension. J Hypertens 1988, 6:389-392.
7. Erne P, Bolli P, Burgisser E, Buhler FR: Correlation of platelet calcium with blood pressure: effect of antihypertensive therapy. N Engl J Med 1984, 310:1084-1088.
8. Bruschi G, Bruschi ME, Caroppo M, Orlandini G, Spaggiari, Cavatorta A: Cytoplasmic free calcium is increased in the platelets of spontaneously hypertensive rats and essential hypertensive patients. Clin Sci 1985, 68:179-184.
9. Lechi A, Lechi C, Bonadonna G, Sinigaglia D, Corradini P, Polignano R, et al.: Increased basal and thrombin-induced free calcium in platelets of essential hypertensive patients. Hypertension 1987, 9:230-235.
10. Kjeldsen SE, Gjesdal K, Leren P, Eide IK: Decreased platelet free dopamine and unchanged noradrenaline and adrenaline in essential hypertension. Thromb Haemost 1988, 60:251-254.
11. Guicheney P, Baudouin-Legros M, Valtier D, Meyer: Reduced serotonin content and uptake in platelets from patients with essential hypertension: is a ouabain-like factor involved? Thromb Res 1987, 45: 289-297.
12. Kjeldsen SE, Neubig RR, Weder AB, Zweifler AJ: The hypertension-coronary heart disease dilemma: the catecholamine-blood platelet connection. J Hypertens 1989, 7:851-860.
13. Bellavite P, Andrioli G, Guzzo P, Arigliano P, Chirumbolo S, Manzato F, et al.: A colorimetric method for the measurement of platelet adhesion in microtiter plates. Anal Biochem 1994, 216:444-450.
14. Abrams C, Shattil SJ: Immunological detection of activated platelets in clinical disorders. Thromb Haemost 1991, 65:467-473.
15. Ault KA: Flow cytometric measurement of platelet function and reticulated platelets. Ann NY Acad Sci 1993, 677:293-308.
16. Lindahl TL, Lundahl J, Netré C, Egberg N: Studies of the platelet fibrinogen receptor in Glanzmann patients and uremic patients. Thromb Res 1992, 67:457-466.
17. Kaplan KL: Laboratory markers of platelet activation. In Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Edited by Colman RW, Hirsh J, Marder VJ, Salzman EW. Philadelphia: J.B. Lippincott Company; 1994:1180-1196.
18. Hawiger J: Mechanisms involved in platelet vessel wall interaction. Thromb Haemost 1995, 74:369-372.
19. Niiya K, Hodson E, Bader R, Byers-Ward V, Koziol JA, Plow EF, et al: Increased surface expression of the membrane glycoprotein IIb/IIIa complex induced by platelet activation. Relationship to the binding to the binding of fibrinogen and platelet aggregation. Blood 1987, 70: 475-483.
20. Zucker MB: Platelet aggregation measured by the photometric method. In Methods in Enzymology. Edited by Hawiger J. San Diego: Academic Press; 1989, 169:117-133.
21. Thompson DB, Jakubowski JA, Quinn PG, Deykin D, Valeri CR: Platelet size as determinant of platelet function. J Lab Clin Med 1983, 101: 205-213.
22. Martin JF, Bath PM, Burr ML: Influence of platelet size on outcome after myocardial infarction. Lancet 1991, 338:1409-1411.
23. D'Erasmo E, Aliberti G, Celi FS, Romagnoli E, Vecci E, Mazzuoli GF: Platelet count mean platelet volume and their relation to prognosis in cerebral infarction. J Intern Med 1990, 227:11-14.
24. Walker JJ, Cameron AD, Bjornsson S, Singer CRJ, Fraser C: Can platelet volume perdict progressive hypertensive disease in pregnancy? Am J Obstet Gynecol 1989, 161:676-679.
25. G-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal. J Hypertens 1992, 10: 1025-1031.
26. Haynes WG, Noon JP, Walker BR, Webb DJ: Inhibition of nitric oxide synthesis increases blood pressure in helthy humans. J Hypertens 1993, 11:1375-1380.
27. Cadwgan TM, Benjamin N: Evidence for altered platelet nitric oxide synthesis in essential hypertension. J Hypertens 1993, 11:417-420.
28. Blann AD, Naqvi T, Waite M, McCollum CN: Von Willebrand factor and endothelial damage in essential hypertension. J Hum Hypertens 1993, 7:107-111.
29. Kloczko J, Wojtukiewicz MZ, Bielawiec M, Galar M, Tarasow E: Von Willebrand factor antigen and fibronectin in essential hypertension. Thromb Res 1995, 79:331-336.
30. Pedrinelli R, Giampietro O, Carmassi F, Melillo E, Dell'Omo G, Catapano G, et al.: Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet 1994, 344:14-18.